11:22 AM EST - Neovasc Inc. : Announced that a patient implanted with a Tiara™ transcatheter mitral valve replacement device has celebrated her fifth anniversary since undergoing the procedure. The Company believes that this patient is the longest surviving transcatheter mitral valve replacement therapy recipient in the world. Neovasc Inc.
shares T.NVCN are trading down $0.02 at $0.88.
